A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Active:	Yes
Cancer Type:	Colon/Rectal Cancer Esophogeal Cancer Solid Tumor Stomach/ Gastric Cancer Unknown Primary	NCT ID:	NCT06657144
Trial Phases:	Phase I	Protocol IDs:	CHS-114-102 (primary) NCI-2025-04098
Eligibility:	18 Years and older, Male and Female	Study Type:	Treatment
Study Sponsor:	Coherus Oncology, Inc.
NCI Full Details:	http://clinicaltrials.gov/show/NCT06657144

Summary

The main purpose of this study is to evaluate the safety and preliminary efficacy of
CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s)
in participants with advanced or metastatic solid tumors.

Treatment Sites in Georgia

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.